Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-07 · accession 0001822629-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-14 | 2025-03-07 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $60.62 | -17.1K | 485.6K | -3% | -$1.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | F | D | 17,060 | $60.62 | 485,634 | D | — | — |